Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2014, Article ID 370286, 3 pages
http://dx.doi.org/10.1155/2014/370286
Case Report

Atypical Presentation of PKDL due to Leishmania infantum in an HIV-Infected Patient with Relapsing Visceral Leishmaniasis

1Department of Clinical and Molecular Biomedicine, Division of Infectious Diseases, University of Catania, Via Palermo 636, 95125 Catania, Italy
2Department of Clinical and Molecular Biomedicine, Unit of Dermatology, University of Catania, 95100 Catania, Italy

Received 15 March 2014; Revised 24 July 2014; Accepted 26 July 2014; Published 14 August 2014

Academic Editor: Paola Di Carlo

Copyright © 2014 Benedetto Maurizio Celesia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Alvar, P. Aparicio, A. Aseffa et al., “The relationship between leishmaniasis and AIDS: the second 10 years,” Clinical Microbiology Reviews, vol. 21, no. 2, pp. 334–359, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Strazzulla, S. Cocuzza, M. R. Pinzone et al., “Isolated laryngeal leishmaniasis in a 55-year-old man with dysphonia and rheumatoid arthritis: case report and literature review,” Acta Medica Mediterranea, vol. 29, pp. 807–810, 2013. View at Google Scholar
  3. A. Strazzulla, S. Cocuzza, M. R. Pinzone et al., “Mucosal leishmaniasis: an underestimated presentation of a neglected disease,” BioMed Research International, vol. 2013, Article ID 805108, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Cocuzza, A. Strazzulla, and M. R. Pinzone, “Isolated laryngeal leishmaniasis in immunocompetent patients: an underdiagnosed disease,” Case Reports in Infectious Diseases, vol. 2013, Article ID 165409, 7 pages, 2013. View at Publisher · View at Google Scholar
  5. E. E. Zijlstra, A. M. Musa, E. A. G. Khalil, I. M. El Hassan, and A. M. El-Hassan, “Post-kala-azar dermal leishmaniasis,” Lancet Infectious Diseases, vol. 3, no. 2, pp. 87–98, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Antinori, E. Longhi, G. Bestetti et al., “Post-kala-azar dermal leishmaniasis as an immune reconstitution inflammatory syndrome in a patient with acquired immune deficiency syndrome,” British Journal of Dermatology, vol. 157, no. 5, pp. 1032–1036, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. A. L. Ridolfo, C. Gervasoni, S. Antinori et al., “Post-kala-azar dermal leishmaniasis during highly active antiretroviral therapy in an AIDS patient infected with leishmania infantum,” Journal of Infection, vol. 40, no. 2, pp. 199–202, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Stark, S. Pett, D. Marriott, and J. Harkness, “Post-kala-azar dermal leishmaniasis due to Leishmania infantum in a human immunodeficiency virus type 1-infected patient,” Journal of Clinical Microbiology, vol. 44, no. 3, pp. 1178–1180, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Boumis, P. Chinello, C. Della Rocca, M. G. Paglia, M. F. Proietti, and N. Petrosillo, “Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient,” International Journal of STD and AIDS, vol. 17, no. 5, pp. 351–353, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Rihl, M. Stoll, K. Ulbricht, F. Bange, and R. Schmidt, “Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in an HIV-infected patient with multiple relapsing leishmaniasis from Western Europe,” The Journal of Infection, vol. 53, no. 1, pp. e25–e27, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Roustan, J. A. Jiménez, B. Gutiérrez-Solar, J. L. Gallego, J. Alvar, and M. Patrón, “Post-kala-azar dermal leishmaniasis with mucosal involvement in a kidney transplant recipient: Treatment with liposomal amphotericin B,” British Journal of Dermatology, vol. 138, no. 3, pp. 526–528, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. G. F. Cota, M. R. de Sousa, and A. Rabello, “Predictors of visceral leishmaniasis relapse in hiv-infected patients: a systematic review,” PLoS Neglected Tropical Diseases, vol. 5, no. 6, Article ID e1153, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Kemp, “Cytokine-producing T cell subsets in human leishmaniasis,” Archivum Immunologiae et Therapiae Experimentalis, vol. 48, no. 3, pp. 173–176, 2000. View at Google Scholar · View at Scopus
  14. M. Clerici and G. M. Shearer, “A TH1TH2 switch is a critical step in the etiology of HIV infection,” Immunology Today, vol. 14, no. 3, pp. 107–111, 1993. View at Publisher · View at Google Scholar · View at Scopus
  15. M. M. Kane and D. M. Mosser, “The role of IL-10 in promoting disease progression in Leishmaniasis,” Journal of Immunology, vol. 166, no. 2, pp. 1141–1147, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Marques, R. Sá, F. Coelho, J. Oliveira, J. S. Da Cunha, and A. Melico-Silvestre, “Miltefosine for visceral leishmaniasis relapse treatment and secondary prophylaxis in HIV-infected patients,” Scandinavian Journal of Infectious Diseases, vol. 40, no. 6-7, pp. 523–526, 2008. View at Publisher · View at Google Scholar · View at Scopus